Airbus Finds A321neo Fuselage Quality Issue 
SpaceXAI to Double Nvidia Chips at Colossus 2 by Year-End 
Suzuki Targets Faster Car Development to Keep Pace With Chinese Rivals 
SoftBank Raises $11.1 Billion in Bond Sale to Fund OpenAI Investment 
Select Water Solutions Shares Surge on $700 Million Pilot Water Deal 
Dubai’s connectivity remains strong in an uncertain world 
Hims & Hers Shares Fall as GLP-1 Costs Widen Q2 Loss 
Costco Revenue Beats Estimates as Inflation Drives Bulk Shopping 
BMW 2028 Margin Target Could Fall Below Consensus, UBS Says 
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim 
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback 
Apple Extends Qualcomm Patent Licensing Deal 
US Backs Musk in Fight Against EU’s €120 Million X Fine 
OpenAI to Preview GPT-6 Cyber AI Model for Cybersecurity 
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline 
McDonald’s Sees Flat Traffic, Sticky Inflation as New Normal 
JPMorgan Names Lavatelli Japan Chief in Leadership Shake-Up 
Add as a preferred source on Google
AstraZeneca plc, a British-Swedish pharmaceutical and biotechnology company, is reportedly withdrawing its COVID-19 vaccine worldwide. The company made the decision months after admitting in court there is a rare side effect.
But then again, according to Channel News Asia, AstraZeneca did not say this was the reason for the pullout of the vaccines. Rather, the company said it was due to “commercial reasons.”
Taking Back the COVID-19 Vaccines Years After Release
AstraZeneca said on Tuesday, May 7, the withdrawal of its vaccines around the world is already underway. It stressed that this is due to a "surplus of available updated vaccines" since the pandemic.
Moreover, the pharmaceutical and biotech firm announced it would also retract the vaccine Vaxzevria's marketing authorizations in Europe. AstraZeneca added that it is no longer producing its COVID-19 vaccine, so supply to the market has also stopped.
“As multiple, variant Covid-19 vaccines have since been developed there is a surplus of available updated vaccines,” the company’s spokesman said in a statement. “This has led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.”
Reported Side Effects of Vaxzevria
AstraZeneca reportedly admitted in court documents that the vaccine has side effects like low platelet counts and blood clots. British newspapers stated that based on legal documents, the company's vaccine may cause TTS, but in very rare cases. World Health Organization (WHO), said this condition called Thrombosis with Thrombocytopenia Syndrome is a serious and life-threatening negative effect.
“It is admitted that the AZ vaccine can, in very rare cases, cause TTS,” AstraZeneca said in court documents in February. “The causal mechanism is not known.”
UK’s The Independent reported that AstraZeneca’s admission came after it was sued in the U.K. The class action lawsuits alleged that the company’s vaccine caused deaths and severe injuries, and claimants are seeking damages up to £100 million for around 50 supposed victims.
Photo by: Mufid Majnun/Unsplash
